Young Li
Stock Analyst at Jefferies
(0.23)
# 4,180
Out of 4,876 analysts
5
Total ratings
33.33%
Success rate
-29.56%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $13.23 | +444.22% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $69.69 | +65.02% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.73 | +70.95% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $32.26 | +85.99% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $10.75 | +327.91% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $13.23
Upside: +444.22%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $69.69
Upside: +65.02%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.73
Upside: +70.95%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $32.26
Upside: +85.99%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $10.75
Upside: +327.91%